Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanobiotix names board member, creates new department

This article was originally published in Clinica

Executive Summary

Nanobiotix, a clinical-stage company developing cancer therapies based on nanoparticles, has named company chief financial officer Philippe Mauberna to its executive board. Mr Mauberna joined the company in May 2013. Furthermore, the Paris, France-based firm has named Sarah Gaubert head of its newly created communication and public affairs department. Prior to joining the firm, Ms Gaubert was an advisor to the French Presidency and several ministries including the Ministry of Health.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100913

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel